Complete coverage on


Dianne has always worried about her heart health -- both her parents died of heart attacks -- yet her cholesterol has never been off the charts. All the same, the 59-year-old schoolteacher (who asked that her last name not be used) has been taking a cholesterol-lowering statin for more than two years.

Latest Stories

FDA considers statin use for those with normal cholesterolupdated: Tue Dec 22 2009 11:57:00

Should people who don't have high cholesterol take a cholesterol-lowering statin? Maybe, according to the U.S. Food and Drug Administration, which is considering an advisory panel's recent recommendation to do just that.

Study: Cholesterol drugs could help those with healthy levelsupdated: Mon Aug 10 2009 14:46:00

Healthy men and women with good cholesterol levels could significantly reduce their risk of heart disease by taking cholesterol-lowering drugs, better known as statins, according to a study released at the American Heart Association meetings in November.

CNNMoney: Chopping costs by cutting pillsupdated: Mon Mar 16 2009 06:38:00

More consumers, struggling to contain medical expenses, are resorting to "pill cutting" to makes their prescriptions last longer. Preventing Heart Failure: Fish Oil?updated: Sun Aug 31 2008 14:00:00

Fish oil supplements may work slightly better than a popular cholesterol-reducing drug to help patients with chronic heart failure

AstraZeneca earning worriesupdated: Mon Nov 05 2007 16:58:00

UK drugmaker AstraZeneca suffers a drop in earnings. CNN's Charles Hodson speaks with CEO David Brennan.

CNNMoney: Diabetic nerve damage breakthrough seenupdated: Sat Jun 23 2007 00:05:00

Cholesterol-lowering statins - which include the world's top-selling drug, Lipitor - and other drugs called fibrates can lower the risk of developing a common form of nerve damage in diabetics that often results in amputations, according to study results unveiled Friday.

CNNMoney: Tough day for heart drugsupdated: Mon Mar 19 2007 11:05:00

An experimental drug from AtheroGenics and its partner AstraZeneca failed a late-stage clinical trial and is not considered an effective treatment in reducing heart disease, the companies said.

CNNMoney: Getting drugs from Canadaupdated: Thu Oct 05 2006 16:14:00

Getting cheaper prescription drugs from Canada just got easier. The Department of Homeland Security won't be confiscating medicine shipped from Canada to the United States. But before you go online, we're going to tell you what you need to know about this policy change.

CNNMoney: Vytorin is better than Crestor, says study from Merck, Schering-Ploughupdated: Mon Jun 19 2006 06:00:00

Merck and Schering-Plough announced a study on Sunday showing that their combination drug Vytorin is better at lowering cholesterol than competing drug Crestor from AstraZeneca.

CNNMoney: New use for AstraZeneca cholesterol drugupdated: Mon Mar 13 2006 06:03:00

Anglo-Swedish pharmaceutical AstraZeneca said Monday that its blockbuster anti-cholesterol treatment Crestor has passed a key scientific trial.

CNNMoney: Vytorin outsells rival cholesterol drugsupdated: Tue Jul 26 2005 13:19:00

Vytorin, a relatively new cholesterol-blocking drug from Merck and Schering-Plough, has outpaced sales of a blockbuster rival, according to a report Monday from Friedman, Billings, Ramsey & Co.

CNNMoney: Drugmakers' TV ad spending tumbling?updated: Tue Jul 05 2005 09:40:00

Drugmakers have cut television ad spending by 10 percent in the first quarter from a year ago, the sharpest decline in two years, a newspaper said Tuesday.

This week in the medical journalsupdated: Thu May 26 2005 11:54:00

The heart of the story

This week in the medical journalsupdated: Thu May 12 2005 11:48:00

The good

Money Magazine: Losing Faith in Wonder Drugs?updated: Wed Dec 01 2004 00:01:00

When Merck yanked the arthritis wonder drug Vioxx off shelves this fall, it not only devastated the company's stock and reputation, it raised fears about the safety of every big new drug. After all...

Fortune: Statins Could Be The Next Aspirinupdated: Mon Aug 09 2004 00:01:00

Will one statin a day keep the doctor away? That's the question Americans and their doctors are asking as medical research suggests the drugs do far more than lower cholesterol. The buzz started ...

CNNMoney: Lipitor Prescriptions Surge After Studyupdated: Thu Mar 18 2004 07:04:00

The share of new prescriptions written for the cholesterol-lowering drug Lipitor surged during the past week as the Pfizer Inc. (PFE) blockbuster got a boost from a big study showing it was better than Bristol-Myers Squibb Co.'s ( BMY) Pravachol in preventing heart attacks, Thursday's Wall Street Journal reported.

Fortune: Scientists believe they may have found a common link in diseases from cancer to Alzheimer's to heart disease. Here's the story bupdated: Mon Oct 27 2003 00:01:00

Actuaries, not economists, are the truly dismal scientists. Consider some actuarial projections about the graying America of 2050: One in 26 of us will have Alzheimer's disease, compared with one i...

Fortune: Healthupdated: Mon Dec 09 2002 00:01:00

Move over, cholesterol. The latest heart-attack culprit is C-reactive protein (CRP). CRP, which is produced when arteries are inflamed, was nailed in a groundbreaking November New England Journal o...

Money Magazine: Medicine Man Hank McKinnell says Pfizer has the best drug pipeline in the business.updated: Fri Jun 01 2001 00:01:00

What do you call a drug company on Viagra? Pfizer, of course.

We recommend